Qyuradyne Biotech Private Limited - Company Profile

It is a paper private limited company based in Mumbai, Maharashtra, India, established in 2023.
2023 Mumbai, Maharashtra, India Active
Last Updated:
About Qyuradyne Biotech Private Limited

Qyuradyne Biotech Private Limited, a active private limited company, was established on 17 May 2023 in Mumbai, Maharashtra, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21001MH2023PTC403125. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹2.00 M.

Its leadership includes Rajalakshmi Mathurakavi Raghavan (Non- Individual Subscriber), Sarada Srinivasa Raghavan (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 5-C, Sett Minar Pedder Road, Mumbai, Maharashtra, 400026.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001MH2023PTC403125

  • Registration Number

    403125

  • Incorporation Date

    17 May 2023

  • Authorized Capital

    ₹2.00 M

  • Paid-Up Capital

    ₹2.00 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 2.00 M
  • Company Age 2 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Qyuradyne Biotech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Qyuradyne Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Qyuradyne Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajalakshmi Mathurakavi Raghavan Non- Individual Subscriber 17 May 2023 Current
Sarada Srinivasa Raghavan Director 17 May 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Qyuradyne Biotech.

Enhance accessibility to Qyuradyne Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Qyuradyne Biotech revenue growth over time
Qyuradyne Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Qyuradyne Biotech?

Unlock access to Qyuradyne Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Qyuradyne Biotech?

Unlock and access historical data on people associated with Qyuradyne Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Qyuradyne Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qyuradyne Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Qyuradyne Biotech
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Qyuradyne Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Qyuradyne Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Rajalakshmi Mathurakavi Raghavan was appointed as a Non- Individual Subscriber was appointed as a Non- Individual Subscriber on 17 May 2023 & has been associated with this company since 2 years 9 months . was documented.

  • Director Appointment

    Progress on Sarada Srinivasa Raghavan was appointed as a Director was appointed as a Director on 17 May 2023 & has been associated with this company since 2 years 9 months . was documented.

  • Company Incorporation

    Progress on Qyuradyne Biotech Private Limited was registered on 17 May 2023 with Roc Mumbai & aged 2 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Qyuradyne Biotech Private Limited?

The CIN of Qyuradyne Biotech Private Limited is U21001MH2023PTC403125.

Where is Qyuradyne Biotech Private Limited headquartered?

Qyuradyne Biotech Private Limited is headquartered at 5-C, Sett Minar Pedder Road, Mumbai, Maharashtra, 400026.

When was Qyuradyne Biotech Private Limited incorporated?

Qyuradyne Biotech Private Limited was incorporated on 17 May 2023.

Who are the current directors of Qyuradyne Biotech Private Limited?

The current directors of Qyuradyne Biotech Private Limited are

What is the primary industry of Qyuradyne Biotech Private Limited?

The primary industry of Qyuradyne Biotech Private Limited is Paper.

Is Qyuradyne Biotech Private Limited a listed company?

Qyuradyne Biotech Private Limited is unlisted.

What is the capital structure of Qyuradyne Biotech Private Limited?

The authorized capital of Qyuradyne Biotech Private Limited is ₹2.00 M, and the paid-up capital is ₹2.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available